Nasdaq Mxct News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq mxct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Mxct Today - Breaking & Trending Today

Valmark Advisers Inc. Buys New Shares in MaxCyte, Inc. (NASDAQ:MXCT)

Valmark Advisers Inc. bought a new stake in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 83,927 shares of the company’s stock, valued at approximately $394,000. Valmark Advisers Inc. owned about 0.08% of MaxCyte […] ....

United States , William Blair , Alberta Investment Management Corp , Maxcyte Company Profile , Maven Securities , Sg Americas Securities , Blair William Co , Exchange Commission , Valmark Advisers Inc , Maxcyte Inc , Valmark Advisers , Free Report , Investment Counsel , Investment Management Corp , Get Free Report , Maxcyte Daily , Nasdaq Mxct , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Stephens Reiterates Overweight Rating for MaxCyte (NASDAQ:MXCT)

Stephens reaffirmed their overweight rating on shares of MaxCyte (NASDAQ:MXCT – Free Report) in a report published on Tuesday, Benzinga reports. The firm currently has a $11.00 price target on the stock. Several other equities analysts have also recently weighed in on the company. BTIG Research lowered their price target on MaxCyte from $10.00 to […] ....

United States , William Blair , China Universal Asset Management Co , Financial Services Group Inc , Maxcyte Inc , Nisa Investment Advisors , Victory Capital Management Inc , Johnson Investment Counsel Inc , Free Report , Get Free Report , Services Group , Capital Management , Investment Counsel , Investment Advisors , China Universal Asset Management , Universal Asset Management , Maxcyte Daily , Nasdaq Mxct , Reiterated Rating ,

MaxCyte Signs Strategic Platform License with Be Biopharma

Be Biopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform within its Engineered B Cell Medicines programs. ....

United Kingdom , Anya Bolshem , Chris Welsh , Maher Masoud , David Deuchler , Bio Bcms , Richard James , Panmure Gordon , Mary Jane Elliott , Emma Earl Freddy Crossley , Rupert Dearden , David Rawlings , Seattle Children Research Institute , Bristol Myers Squibb , Maxcyte Inc , Longwood Fund , Gilmartin Group , Atlas Venture , Engineeredb Cell Medicines , Seattle Children , Alta Partners , Takeda Ventures , Research Institute , Cyte Contacts , Joint Corporate , Bio Contacts ,

MaxCyte to Report Fourth Quarter and Full Year 2023

ROCKVILLE, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing. ....

United Kingdom , Panmure Gordon , David Deuchler , Rupert Dearden , Mary Jane Elliott , Emma Earl Freddy Crossley , Chris Welsh , Digital Health , Gilmartin Group , Maxcyte Inc , Life Science , Diagnostic Tools , Annual Cowen Healthcare , Cyte Contacts , Joint Corporate , Freddy Crossley , Jane Elliott , Nasdaq Mxct ,

MaxCyte, Inc. (NASDAQ:MXCT) Director Sells $25,600.00 in Stock

MaxCyte, Inc. (NASDAQ:MXCT – Get Free Report) Director John Joseph Johnston sold 5,000 shares of MaxCyte stock in a transaction on Friday, January 26th. The shares were sold at an average price of $5.12, for a total transaction of $25,600.00. Following the completion of the sale, the director now owns 120,583 shares in the company, […] ....

United States , Craig Hallum , John Joseph Johnston , William Blair , Tower Research Capital , Victory Capital Management Inc , Royal Bank , Johnson Investment Counsel Inc , Maxcyte Inc , Get Free Report , Director John Joseph Johnston , Joseph Johnston , Capital Management , Investment Counsel , Research Capital , Maxcyte Daily , Nasdaq Mxct , Insider Trading , Nsider Trades ,